|
Market Closed -
Nasdaq
16:00:00 2026-10-20 EDT
|
5-day change | 1st Jan Change | ||
| 807.48 USD | +3.25% |
|
+7.22% | +4.61% |
| 10-20 | AstraZeneca-Amgen asthma drug hits 69% remission in esophageal disease trial | RE |
| 10-19 | Major drugmakers turn to China for licensing deals | RE |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +3.25% | +7.22% | +2.88% | +20.13% | +4.61% | +40.00% | -0.12% | +43.50% | +117.51% | 80.63B | |
| +3.49% | +10.04% | +11.34% | +11.92% | +19.45% | +58.68% | +119.56% | +426.69% | +1,530.25% | 1,144B | |
| +2.19% | +4.32% | -3.94% | +4.24% | +25.32% | +33.88% | +69.52% | +58.36% | +125.79% | 625B | |
| +2.26% | +5.37% | +9.52% | +14.09% | +26.52% | +24.57% | +97.69% | +166.65% | +368.07% | 511B | |
| -0.78% | +4.50% | +6.25% | +16.12% | +18.10% | +38.03% | +63.17% | +8.33% | +66.85% | 377B | |
| +3.25% | +4.45% | +0.97% | +19.21% | +40.89% | +71.80% | +44.44% | +82.93% | +139.50% | 366B | |
| -0.41% | +2.80% | +8.58% | +0.45% | +15.05% | +20.60% | +49.23% | +62.60% | +68.36% | 291B | |
| -0.50% | +2.31% | +0.19% | +0.74% | -8.75% | +0.88% | +24.59% | +41.98% | +154.12% | 262B | |
| +3.29% | +6.32% | +13.82% | +20.53% | +34.11% | +44.71% | +57.43% | +109.36% | +171.79% | 237B | |
| +2.25% | +5.81% | +4.26% | +17.49% | +27.51% | +27.13% | +101.17% | +134.09% | +110.62% | 194B | |
| -0.60% | +1.29% | -0.29% | -20.00% | -20.29% | -26.96% | -62.00% | -22.37% | +82.83% | 174B | |
| +2.28% | +6.13% | +8.86% | +21.66% | +20.92% | +21.95% | -1.76% | -29.65% | -7.47% | 172B | |
| +2.53% | +6.07% | +1.24% | +7.11% | +13.52% | +22.80% | +42.22% | +177.45% | +520.66% | 130B | |
| +4.84% | +8.84% | -2.19% | +2.53% | +14.35% | +41.50% | +9.25% | +6.22% | +22.48% | 126B | |
| +1.95% | +7.09% | +17.78% | +23.89% | +25.58% | +30.76% | +127.49% | +399.84% | +536.07% | 120B | |
| -0.64% | +2.51% | -2.59% | -1.66% | +2.03% | +13.13% | +27.29% | +5.56% | -10.21% | 100B | |
| -0.56% | +1.82% | -1.96% | -4.72% | -11.59% | -15.25% | -25.61% | -12.89% | +5.68% | 99.04B | |
| +6.69% | +11.94% | +57.15% | +306.93% | +720.89% | +788.69% | +201.09% | -27.31% | - | 96.65B | |
| -0.41% | +2.71% | +9.92% | +8.57% | +18.88% | +26.96% | +0.62% | -28.34% | +47.58% | 71.51B | |
| +1.26% | +7.80% | -2.09% | -11.98% | -21.01% | -9.04% | +44.08% | +67.94% | +449.45% | 66.89B | |
| Average | +0.97% | +5.36% | +6.99% | +22.86% | +48.30% | +62.74% | +49.47% | +83.55% | +236.84% | 262.23B | |
| Weighted average by Cap. | +0.79% | +4.99% | +6.50% | +15.26% | +31.40% | +48.65% | +68.23% | +150.66% | +467.57% |
- Stock Market
- Stocks
- REGN Stock
- Sector Regeneron Pharmaceuticals, Inc.
Select your edition
All financial news and data tailored to specific country editions
